CRH ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
310Congenital anomalies syndrome1

310. Congenital anomalies syndrome


Clinical trials : 11 Drugs : 20 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 7
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00001721
(ClinicalTrials.gov)
September 13, 19983/11/1999Study of Smith-Lemli-Opitz SyndromeClinical and Basic Investigations Into Smith-Lemli-Opitz SyndromeSmith-Lemli-Opitz SyndromeDrug: Cholesterol Suspension;Drug: CRH;Drug: CholesterolEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NULLCompletedN/AN/AAll130United States